<s>[INST] The next text is a question of a member of the European parliament:"At present, there is not a sufficiently level playing field, or sufficient diversity of supply, on the European market for medicinal products. This means that the prices of medicines remain high, while a number of Member States have already stated that they are not prepared to buy medicines at such prices. Higher prices restrict the availability of medicines for patients. There is little cooperation among Member States in this field, with the result that demand for products from pharmaceutical companies does not change much. The Dutch Minister, MsSchippers, has already attempted to buy medicines more cheaply together with some of her counterparts, and has also stated her intention of tackling the matter during the Netherlands' Presidency.  1.Is the Commission familiar with the current situation in Europe, in which the prices of medicines are high and there is little flexibility to permit Member States to opt for alternatives?  2.What will the Commission do to create more competition and a level playing field on the market for medicines, and thus to bring prices down?"
Analyze carefully the text and assign it to the most relevant policy area among those listed below. Do not explain your answer and return only a number.
Policy area numbers: 1 = Macroeconomics
2 = Civil Rights, Minority Issues and Civil Liberties
3 = Health
4 = Agriculture and Fisheries
5 = Labour, employment and pensions
6 = Education
7 = Environment
8 = Energy
9 = Immigration
10 = Transportation
12 = Law and Crime
13 = Social welfare
14 = Regional and Urban issues and Planning
15 = Banking, finance and domestic commerce issues
16 = Defence
17 = Space, science, technology, and communications issues
18 = Foreign trade
19 = International affairs and foreign aid
20 = Governance and government
21 = Public Lands, Water Management and Territorial Issues
23 = Culture and media
[/INST]. Answer = [3]. </s>
At present, there is not a sufficiently level playing field, or sufficient diversity of supply, on the European market for medicinal products. This means that the prices of medicines remain high, while a number of Member States have already stated that they are not prepared to buy medicines at such prices. Higher prices restrict the availability of medicines for patients. There is little cooperation among Member States in this field, with the result that demand for products from pharmaceutical companies does not change much. The Dutch Minister, MsSchippers, has already attempted to buy medicines more cheaply together with some of her counterparts, and has also stated her intention of tackling the matter during the Netherlands' Presidency.  1.Is the Commission familiar with the current situation in Europe, in which the prices of medicines are high and there is little flexibility to permit Member States to opt for alternatives?  2.What will the Commission do to create more competition and a level playing field on the market for medicines, and thus to bring prices down?